A novel molecular platform for co-delivery of monomethyl auristatin E and ispinesib to prostate cancer cells

A conjugate for co-delivery of ispinesib and monomethyl auristatin E was prepared using methods of peptide synthesis and azide-alkyne cycloaddition. Cytotoxicity studies of the mentioned drug pair were performed. In vitro studies of the synthesized bimodal conjugate were conducted on prostate cancer cell lines.

Авторы
Zyk N.Y. 1 , Kolchanova A.Y. 1 , Volkova N.S. 1 , Uspenskaia A.A. 1 , Skvortsov D.A. 1 , Beloglazkina E.K. 1 , Zyk N.V. 1 , Majouga A.G. 2 , Machulkin A.E. 1, 3
Издательство
Elsevier Science Publishing Company, Inc.
Номер выпуска
4
Язык
English
Страницы
440-443
Статус
Published
Том
35
Год
2025
Организации
  • 1 M. V. Lomonosov Moscow State University
  • 2 D. I. Mendeleev University of Chemical Technology of Russia
  • 3 Peoples Friendship University of Russia (RUDN University)
Ключевые слова
prostate cancer; prostate specific membrane antigen; bimodal conjugates; monomethyl auristatin E; ispinesib; peptide synthesis; azide-alkyne cycloaddition
Цитировать
Поделиться

Другие записи

Avatkov V.A., Apanovich M.Yu., Borzova A.Yu., Bordachev T.V., Vinokurov V.I., Volokhov V.I., Vorobev S.V., Gumensky A.V., Иванченко В.С., Kashirina T.V., Матвеев О.В., Okunev I.Yu., Popleteeva G.A., Sapronova M.A., Свешникова Ю.В., Fenenko A.V., Feofanov K.A., Tsvetov P.Yu., Shkolyarskaya T.I., Shtol V.V. ...
Общество с ограниченной ответственностью Издательско-торговая корпорация "Дашков и К". 2018. 411 с.